Safety assessment of functional oligooctasaccharide riclinoctaose: A pilot study of genotoxicity, acute toxicity, and subchronic toxicity

Abstract

Riclinoctaose was produced by enzymatic hydrolysis of a succinoglycan-type exopolysaccharide riclin. It can be used as a prebiotic to regulate the composition of gut microbiota. Therefore, a safety evaluation is needed. Here, we reported the safety data generated on riclinoctaose. Standard in vitro genotoxicity tests such as the bacterial reverse mutation assay and in vivo micronucleus assay were performed and no mutagenic or clastogenic potential was found. In the acute toxicity study, ICR mice were administered with riclinoctaose via gavage in 14-day studies at the level corresponding to 3000 mg/kg BW/day. In the subchronic study, the diets containing 0%, 1.0%, 2.5%, and 5.0% of riclinoctaose (weight/weight) were prepared for ICR mice for 13 weeks. No test item-related adverse effects were observed in the acute and subchronic studies. No riclinoctaose-induced differences in the overall health, body weight gain, food and water consumption, hematology, blood chemistry, gross pathology, histopathology, or animal death were observed. A no-observed-adverse-effect level of 8842 mg/kg BW/day for male and 9230 mg/kg BW/day for female mice was identified for riclinoctaose when administered for 13 weeks. In conclusion, these findings demonstrated the safety of riclinoctaose and indicated the possibility that riclinoctaose may be used as a functional food.

New Polyvinyl Alcohol/Succinoglycan-Based Hydrogels for pH-Responsive Drug Delivery

“…PVA has been widely used in the biomedical field because of its high biocompatibility, with the acute oral toxicity of PVA also highlighted (LD 50 = 15-20 g/kg) [64]. SG has also been confirmed as a biocompatible polymer in previously reported papers [65,66].…”

Edible freshwater snail (Paludomas conica) attenuates STZ‐induced diabetic complications by regulating PFK‐1 and PON‐1 gene expression

“…After administration, food was withheld for 3–4 h. Individual observations of the experimental animals were made for the first 30 min after dosing, then at regular intervals for the first 24 h (with extra focus on the first 4 h), with an emphasis on looking for any unusual reactions, such as behavioural changes, allergic syndromes (itching, swelling, skin, or rash) and mortality over the following 72 h. The entire observation was sustained for the next 14 days. The median therapeutic effective dose was intervened as one‐tenth of the median lethal dose (LD50 > 2.0 g/kg) (Wang et al ., 2022).…”

Optimization of Extraction Process, Preliminary Characterization and Safety Study of Crude Polysaccharides from Morindae Officinalis Radix

“…Most active extracts derived from herbal medicines are considered safe, but some of them have known toxicities [ 35 , 36 ]. Therefore, the scientific evaluation and basis for the safety of extracts are considered important and essential [ 37 , 38 , 39 ]. The crude polysaccharides extracted from MOR have diverse pharmacological effects, which indicates great potential for applications in the development of new food raw material or functional food.…”